Results 71 to 80 of about 218 (97)

Endothelium-Dependent Nitric Oxide-Mediated Vasorelaxant Effects of BPC 157 in Human Internal Mammary Artery. [PDF]

J Clin Med
Yildirim AK, Dastan AO, Demeli Ertus M, Ensarioglu M, Karabacak K, Pehlivanoglu B.   +5 more
europepmc   +1 more source

Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT). [PDF]

Inflammopharmacology
Whitehouse M.
europepmc   +1 more source

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. [PDF]

Int J Mol Sci
Yuan C, Demers A, Silva-Ortiz V, Hasoon JJ, Lee W, Dave K, Amirdelfan K, Burke HW, Christo PJ, Robinson CL.   +9 more
europepmc   +1 more source

Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. [PDF]

Pharmaceuticals (Basel)
Józwiak M, Bauer M, Kamysz W, Kleczkowska P.   +3 more
europepmc   +1 more source

Protective Effects of BPC 157 on Liver, Kidney, and Lung Distant Organ Damage in Rats with Experimental Lower-Extremity Ischemia-Reperfusion Injury. [PDF]

Medicina (Kaunas)
Demirtaş H, Özer A, Yıldırım AK, Dursun AD, Sezen ŞC, Arslan M.   +5 more
europepmc   +1 more source

Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. [PDF]

Yale J Biol Med
Cushman CJ, Ibrahim AF, Smith AD, Hernandez EJ, MacKay B, Zumwalt M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy

Current Pharmaceutical Design, 2020
This review is focused on the healing of fistulas and stable gastric pentadecapeptide BPC 157. Assuming that the healing of the various wounds is essential also for the gastrointestinal fistulas healing, the healing effect on fistulas in rats, consistently noted with the stable gastric pentadecapeptide BPC 157, may raise several interesting ...
Robert Klicek, Ivan Krezić, Katarina Kasnik Kovac   +2 more
exaly   +6 more sources

Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways

Current Medicinal Chemistry, 2023

Katarina Oroz
exaly   +3 more sources

Stable Gastric Pentadecapeptide BPC 157 and NO-System

2023
Stable gastric pentadecapeptide BPC 157 is known with very safe profile when used to be in ulcerative colitis and now multiple sclerosis trial, lethal dose (LD1) not achieved. Its pleiotropic beneficial effects were largely combined with its particular modulatory effect on NO-system functions, providing that BPC 157 may counteract adverse effect of ...
Predrag Sikiric, Domagoj Drmic, Alenka Boban Blagaic, Ante Tvrdeic, Ivan Krezic, Slaven Gojkovic, Helena Zizek, Suncana Sikiric, Sanja Strbe, Ivan Marija Smoday, Eva Lovric, Anita Skrtic, Sven Seiwerth   +12 more
openaire   +2 more sources

Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157

Current Medicinal Chemistry, 2012
Stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, M.W. 1419) may be the new drug stable in human gastric juice, effective both in the upper and lower GI tract, and free of side effects. BPC 157, in addition to an antiulcer effect efficient in therapy of inflammatory bowel disease (IBD) (PL 14736) so far only tested in clinical phase II, has a ...
P, Sikiric, S, Seiwerth, R, Rucman, B, Turkovic, D S, Rokotov, L, Brcic, M, Sever, R, Klicek, B, Radic, D, Drmic, S, Ilic, D, Kolenc, V, Stambolija, Z, Zoricic, H, Vrcic, B, Sebecic   +15 more
  +5 more sources